BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 24507536)

  • 1. Neuromyelitis optica (Devic's syndrome).
    Wingerchuk DM; Weinshenker BG
    Handb Clin Neurol; 2014; 122():581-99. PubMed ID: 24507536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].
    Asgari N; Skejø HP; Lillevang ST; Stenager E
    Ugeskr Laeger; 2013 May; 175(19):1331-5. PubMed ID: 23663369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
    Crout TM; Parks LP; Majithia V
    Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of neuromyelitis optica.
    Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG
    Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].
    Jordan B; Eger K; Kornhuber ME; Zierz S
    Fortschr Neurol Psychiatr; 2008 Jan; 76(1):21-7. PubMed ID: 18189220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and classification of neuromyelitis optica (Devic's syndrome).
    Drori T; Chapman J
    Autoimmun Rev; 2014; 13(4-5):531-3. PubMed ID: 24424197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromyelitis optica: changing concepts.
    Jacob A; Matiello M; Wingerchuk DM; Lucchinetti CF; Pittock SJ; Weinshenker BG
    J Neuroimmunol; 2007 Jul; 187(1-2):126-38. PubMed ID: 17512987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuromyelitis optica in children. Two case reports].
    Tosello B; Halbert C; Mancini J; Chabrol B; Boucraut J; Milh M
    Arch Pediatr; 2012 Aug; 19(8):827-31. PubMed ID: 22789744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuromyelitis optica].
    Kvistad SA; Wergeland S; Torkildsen Ø; Myhr KM; Vedeler CA
    Tidsskr Nor Laegeforen; 2013 Oct; 133(19):2057-61. PubMed ID: 24129537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuromyelitis optica: a clinical update].
    Chiquete E; Navarro-Bonnet J; Ayala-Armas R; Gutiérrez-Gutiérrez N; Solórzano-Meléndez A; Rodríguez-Tapia D; Gómez-Rincón M; Ruiz-Sandoval JL
    Rev Neurol; 2010 Sep; 51(5):289-94. PubMed ID: 20669128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica: an update.
    Matà S; Lolli F
    J Neurol Sci; 2011 Apr; 303(1-2):13-21. PubMed ID: 21300379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Devic's neuromyelitis optica: a critical review.
    Lana-Peixoto MA
    Arq Neuropsiquiatr; 2008 Mar; 66(1):120-38. PubMed ID: 18392436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of neuromyelitis optica (NMO) in childhood.
    Tillema JM; McKeon A
    J Child Neurol; 2012 Nov; 27(11):1437-47. PubMed ID: 22859697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuromyelitis optica/Devic's syndrome: new perspectives].
    Lalive PH; Perrin L; Chofflon M
    Rev Med Suisse; 2007 Apr; 3(106):950-5. PubMed ID: 17575971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
    Jarius S; Wildemann B
    Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Devic's neuromyelitis optica and related neurological disorders].
    Marignier R; Confavreux C
    Presse Med; 2010 Mar; 39(3):371-80. PubMed ID: 20116202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.